Table 2 Summary of clinical target volume (CTV) statistics.
From: Interobserver variability in clinical target volume delineation in anal squamous cell carcinoma
Parameters | Patient 1 | Patient 2 | Patient 3 | |||
|---|---|---|---|---|---|---|
CTV-inguinal | CTV-pelvis | CTV-inguinal | CTV-pelvis | CTV-inguinal | CTV-pelvis | |
Volume minimum (cm3) | 65.08 | 409.89 | 107.69 | 406.65 | 34.66 | 435.95 |
Volume maximum (cm3) | 264.72 | 947.81 | 284.87 | 918.32 | 151.74 | 879.63 |
Volume mean (cm3) | 181.37 | 633.30 | 185.04 | 658.32 | 91.69 | 609.24 |
SD (cm3) | 65.33 | 158.98 | 65.37 | 140.16 | 35.59 | 143.21 |
Volume union (cm3) | 369.27 | 1129.17 | 386.54 | 1195.15 | 185.08 | 1150.10 |
Volume intersection (cm3) | 50.65 | 250.16 | 40.86 | 262.05 | 28.31 | 215.00 |
Volume of STAPLE generated contour with confidence level of 80% | 212.91 | 716.78 | 226.53 | 730.22 | 105.95 | 688.08 |
Overall kappa | 0.58 | 0.66 | 0.54 | 0.68 | 0.60 | 0.64 |
Mean sensitivity | 0.69 | 0.76 | 0.65 | 0.77 | 0.67 | 0.75 |
SD of sensitivity | 0.24 | 0.14 | 0.23 | 0.13 | 0.23 | 0.14 |
Mean specificity | 0.98 | 0.98 | 0.98 | 0.98 | 0.99 | 0.98 |
SD of specificity | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
p-value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CIgen | 0.48 | 0.55 | 0.45 | 0.53 | 0.49 | 0.52 |
